Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis ; volume:12 ; number:1 ; day:11 ; month:3 ; year:2015 ; pages:1-5 ; date:12.2015
Journal of neuroinflammation ; 12, Heft 1 (11.3.2015), 1-5, 12.2015
- Urheber
-
Malhotra, Sunny
Fissolo, Nicolas
Tintoré, Mar
Wing, Ana Cristina
Castilló, Joaquin
Vidal-Jordana, Angela
Montalban, Xavier
Comabella, Manuel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-015-0269-9
- URN
-
urn:nbn:de:101:1-2021082320352744071037
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Malhotra, Sunny
- Fissolo, Nicolas
- Tintoré, Mar
- Wing, Ana Cristina
- Castilló, Joaquin
- Vidal-Jordana, Angela
- Montalban, Xavier
- Comabella, Manuel
- SpringerLink (Online service)
Ähnliche Objekte (12)
High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
Die Rolle von High Mobility Group Box 1 Protein (HMGB1) in der Immunpathogenese der Pneumokokkenmeningitis
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Diagnostisches und prognostisches Potenzial des Biomarkers High-Mobility Group Box 1 (HMGB1) in kritisch kranken Patienten
Die Rolle des entzündungsassoziierten Gefahrensignals High Mobility Group Box 1 (HMGB1) in der Immunpathogenese der Psoriasis vulgaris
High-mobility group box 1 protein (HMGB1) from Cherry Valley duck mediates signaling pathways and antiviral activity
High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis
Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
Die Rolle von High Mobility Group Box 1 Protein (HMGB1) in der Immunpathogenese der Pneumokokkenmeningitis
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Diagnostisches und prognostisches Potenzial des Biomarkers High-Mobility Group Box 1 (HMGB1) in kritisch kranken Patienten
Die Rolle des entzündungsassoziierten Gefahrensignals High Mobility Group Box 1 (HMGB1) in der Immunpathogenese der Psoriasis vulgaris
High-mobility group box 1 protein (HMGB1) from Cherry Valley duck mediates signaling pathways and antiviral activity
High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis
Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)
High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
Die Rolle von High Mobility Group Box 1 Protein (HMGB1) in der Immunpathogenese der Pneumokokkenmeningitis
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Diagnostisches und prognostisches Potenzial des Biomarkers High-Mobility Group Box 1 (HMGB1) in kritisch kranken Patienten
Die Rolle des entzündungsassoziierten Gefahrensignals High Mobility Group Box 1 (HMGB1) in der Immunpathogenese der Psoriasis vulgaris
High-mobility group box 1 protein (HMGB1) from Cherry Valley duck mediates signaling pathways and antiviral activity
High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis
Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer